Related references
Note: Only part of the references are listed.Development and Evaluation of a Pharmacogenomics Educational Program for Pharmacists
Christine M. Formea et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2013)
Evidence-Based Management of Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Anne Holbrook et al.
CHEST (2012)
Decreased Warfarin Clearance Associated With the CYP2C9 R150H (*8) Polymorphism
Y. Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Strategies for Personalized Medicine-Based Research and Implementation in the Clinical Workflow
W. Lieb et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Implementing Personalized Medicine: Development of a Cost-Effective Customized Pharmacogenetics Genotyping Array
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
A Clinician-Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Association of the GGCX (CAA) 16/17 repeat polymorphism with higher warfarin dose requirements in African Americans
Larisa H. Cavallari et al.
PHARMACOGENETICS AND GENOMICS (2012)
Assessment of healthcare students' views on pharmacogenomics at the University of Minnesota
Meg Moen et al.
PHARMACOGENOMICS (2012)
Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans
Adam Bress et al.
PHARMACOGENOMICS (2012)
Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy
Shanna K. O'Connor et al.
PHARMACOGENOMICS (2012)
The future of warfarin pharmacogenetics in under-represented minority groups
Larisa H. Cavallari et al.
FUTURE CARDIOLOGY (2012)
Assessment of the Pharmacogenomics Educational Needs of Pharmacists
Kristen B. McCullough et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2011)
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource
Ellen M. McDonagh et al.
BIOMARKERS IN MEDICINE (2011)
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
The Missing Association: Sequencing-Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans
M. A. Perera et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Role of Pharmacogenomics in the Management of Traditional and Novel Oral Anticoagulants
Larisa H Cavallari et al.
PHARMACOTHERAPY (2011)
Pharmacogenomics in the Curricula of Colleges and Schools of Pharmacy in the United States
John E. Murphy et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2010)
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
Nita A. Limdi et al.
BLOOD (2010)
Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans
L. H. Cavallari et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Updated Guidelines for Manuscripts Describing Instructional Design and Assessment: The IDEAS Format
Therese Poirier et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Report of the 2007-2008 Argus Commission: What Future Awaits Beyond Pharmaceutical Care?
Barbara G. Wells et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2008)
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
B. F. Gage et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans
H. Schelleman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
A required course in human genomics, pharmacogenomics, and bioinformatics
Daniel A. Brazeau et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2006)
In-vitro and in-vivo effects of the CYP2C9*11 polymorphism on warfarin metabolism and dose
GY Tai et al.
PHARMACOGENETICS AND GENOMICS (2005)
Share Paper
